Suchergebnisse
Vor 4 Tagen · Genmab A/S ist ein international tätiges Biotechnologie-Unternehmen. Das Unternehmen entwickelt humane Antikörpertherapeutika für die Behandlung von Krebs und anderen Krankheiten.
- Jan Winkel
- Dänemark
- 1998
- 2.204
Vor 2 Tagen · View Genmab’s share performance on the Copenhagen stock market and NASDAQ Global Select Market.
Vor 4 Tagen · Stock analysis for Genmab A/S (GMAB:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
30. Juni 2024 · Genmab A/S is a Denmark-based international biotechnology company. It specializes in the creation and development of antibody therapeutics for the treatment of cancer.
- 70 20 27 28
Vor einem Tag · Genmab A/S Announces That the U.S. Food and Drug Administration Approved Epkinly® (Epcoritamab-Bysp) for the Treatment of Adults with Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic EPKINLY
- (17)
- GENMAB A/S
28. Juni 2024 · Get a real-time Genmab A/S (GMAB) stock price quote with breaking news, financials, statistics, charts and more.
Vor 4 Tagen · Genmab (WKN 565131; ISIN: DK0010272202): Kurs & Aktienchart in Echtzeit. Live Realtime-Kurs Realtime-Push .